Literature DB >> 15730230

Obesity, lutein metabolism, and age-related macular degeneration: a web of connections.

Elizabeth J Johnson1.   

Abstract

Age-related macular degeneration (AMD) is a major cause of visual impairment in the United States. Currently there is no effective cure for this disease. Risk factors include decreased lutein and zeaxanthin status and obesity. Obesity is also an increasing public health concern. The alarming increase in the prevalence of obesity further exacerbates the public health concern of AMD. The mechanism by which obesity increases the risk of AMD may be related to the physiologic changes that occur with this condition. These include increased oxidative stress, changes in the lipoprotein profile, and increased inflammation. These changes would also result in an increased destruction and a decreased circulatory delivery of lutein and zeaxanthin to the macula of the eye. Therefore, the mechanism by which obesity is related to AMD risk may be through indirect effects on changes in lutein and zeaxanthin status and metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730230     DOI: 10.1111/j.1753-4887.2005.tb00105.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  20 in total

1.  Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?

Authors:  Renu A Kowluru; Qing Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

Review 2.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 3.  Genetics of age-related macular degeneration: current concepts, future directions.

Authors:  Margaret M Deangelis; Alexandra C Silveira; Elizabeth A Carr; Ivana K Kim
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

4.  Macular pigment and serum zeaxanthin levels with Goji berry supplement in early age-related macular degeneration.

Authors:  Shang Li; Na Liu; Li Lin; Er-Dan Sun; Jian-Da Li; Peng-Kun Li
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

5.  Depletion of serum carotenoid and other fat-soluble vitamin concentrations following obesity surgery.

Authors:  Fernando Granado-Lorencio; Alberto Simal-Antón; Inmaculada Blanco-Navarro; Teresa González-Dominguez; Belén Pérez-Sacristán
Journal:  Obes Surg       Date:  2011-10       Impact factor: 4.129

6.  Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach.

Authors:  Alexandra C Silveira; Margaux A Morrison; Fei Ji; Haiyan Xu; James B Reinecke; Scott M Adams; Trevor M Arneberg; Maria Janssian; Joo-Eun Lee; Yang Yuan; Debra A Schaumberg; Maria G Kotoula; Evangeline E Tsironi; Aristoteles N Tsiloulis; Dimitrios Z Chatzoulis; Joan W Miller; Ivana K Kim; Gregory S Hageman; Lindsay A Farrer; Neena B Haider; Margaret M DeAngelis
Journal:  Vision Res       Date:  2009-09-26       Impact factor: 1.886

Review 7.  [Lutein and antioxidants in the prevention of age-related macular degeneration].

Authors:  M Rehak; E Fric; P Wiedemann
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

8.  Hypocarotenemia after bariatric surgery: a preliminary study.

Authors:  F Granado-Lorencio; C Herrero-Barbudo; B Olmedilla-Alonso; I Blanco-Navarro; B Pérez-Sacristán
Journal:  Obes Surg       Date:  2008-03-28       Impact factor: 4.129

9.  Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration.

Authors:  Eunyoung Cho; Susan E Hankinson; Bernard Rosner; Walter C Willett; Graham A Colditz
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

10.  Associations between body mass index and the prevalence of low micronutrient levels among US adults.

Authors:  Joel E Kimmons; Heidi Michels Blanck; Beth Carlton Tohill; Jian Zhang; Laura Kettel Khan
Journal:  MedGenMed       Date:  2006-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.